
INOGEN INC
INGNNASDAQTrading Snapshot
- Day Range
- $989.21 β $1,007.70
- 52-Week Range
- $5.34 β $9.13
- Volume
- $3.84B
- Avg Volume
- $2.68B
- Shares Outstanding
- 27.1M
- Next Earnings
- Sep 13, 2026
Fundamentals Snapshot
- Annual Revenue
- $349M
- Last Q Revenue
- $95M
- P/E Ratio
- β
- P/S Ratio
- 0.5x
- EPS (TTM)
- $-0.92
- Dividend Yield
- β
Why Investors Own INGN
- βHigh-growth profile β revenue up +25.5% YoY with expanding US Equity exposure.
- βHealthy economics β 73% gross margin and 6% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About INOGEN INC
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
INOGEN INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift INGN price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
INOGEN INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.